Merck Collaborates with GlaxoSmithKline to evaluate novel combination regimen for advanced renal cell carcinoma
18 December 2013 | By Merck
“Collaborations like this are central to Merck’s strategy to evaluate the potential of MK-3475 for the treatment of cancer..."